Ohio State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ohio State University sits in the top decile of US sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count).

552 total trials 117 currently recruiting 319 completed early-phase tilt top decile by trial count

Ohio State University: 552 sponsored US clinical trials, 117 recruiting.

Ohio State University sponsors 552 registered US clinical trials on ClinicalTrials.gov, 117 of them currently recruiting, and 319 completed. 39 of these trials are in Phase 3-4 (later-stage) and 60 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Suicidal Ideation, with 8 trials.

Top-decile sponsor footprint

Ohio State University ranks in the top decile of sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 57/100

319 of 366 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

552 total, page 8 of 12

COMPLETED Phase 4

Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia

NCT03171480

COMPLETED NA

Enhancing Permanency in Children and Families

NCT04700696

COMPLETED NA

Increasing Activity Post-Kidney Transplant With SystemCHANGE

NCT03191630

TERMINATED NA

FAME: Functional Assessment of a Myoelectric Orthosis Hand Orthoses

NCT04266158

TERMINATED NA

Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy

NCT03198156

TERMINATED NA

A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic Surgery

NCT03244683

COMPLETED NA

Continence Pessary Versus Disposable Intravaginal Device Trial

NCT03174431

COMPLETED NA

COPE for Children With Asthma: Intervention for Children With Asthma

NCT03481673

COMPLETED NA

Pictorial Warning Labels & Memory for Relative & Absolute Cigarette Health-risk Information Over Time in Adult Smokers

NCT03499340

COMPLETED NA

Exposure to Gun Violence in Video Games Increases Interest in Real Guns

NCT03259139

COMPLETED

Evaluation of the EasySense System in Congestive Heart Failure

NCT03237923

TERMINATED Phase 4

Epidural Fentanyl for 2nd Stage Labor Analgesia

NCT03120780

COMPLETED

Post Acute Pancreatitis Pancreatic Exocrine Insufficiency

NCT03063398

COMPLETED NA

Urban Zen Integrative Therapy for Persons With Pulmonary Hypertension

NCT03194438

COMPLETED NA

Computerized Cognitive Training in Breast Cancer Survivors

NCT05570604

COMPLETED Phase 2

An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

NCT03137160

COMPLETED

Summer Weight and Environmental Assessment Trial

NCT03010644

COMPLETED

Advance Care Planning GuideTailored for Primary Care Patients

NCT03906773

COMPLETED Phase 2

Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access

NCT03276494

COMPLETED NA

Movement and Music Intervention for Individuals With Dementia

NCT03121950

COMPLETED

Intraoperative Echocardiographic Evaluation of Pulmonary Vein Velocities and Outcomes in Lung Transplantation

NCT03052153

COMPLETED Phase 4

Tear Lipid Layer Thickness With Emollient Eye Drops

NCT03380624

COMPLETED NA

Summer Harvest Adventure: A Garden-based Obesity Prevention Program for Children Residing in Low-resource Communities

NCT05367674

COMPLETED NA

Heart Failure Insomnia Treatment Study

NCT03636880

TERMINATED Phase 1

Spinal Cord Injury Neuroprotection With Glyburide

NCT02524379

COMPLETED NA

Accommodative Relief for Uncomfortable Non-Presbyopes

NCT03544216

COMPLETED

OSUWMC EEI Sequential Cataract Patient Experience Project

NCT03002688

TERMINATED

Prospective Follow-up of Elderly Patients Undergoing Instrumented Lumbar Arthrodesis Supplemented by the Implanet Jazz System(TM)

NCT03434223

COMPLETED NA

High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside

NCT02943109

COMPLETED NA

The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids

NCT02922062

COMPLETED NA

Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion

NCT02970006

COMPLETED NA

Collaborative Lifestyle Intervention Program in Knee Osteoarthritis Patients

NCT02835326

TERMINATED

Opioid Consumption After Hospital Discharge in Orthopedic Surgery

NCT03185117

COMPLETED NA

A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE)

NCT02897024

COMPLETED Early Phase 1

Probiotics for Quality of Life in Autism Spectrum Disorders

NCT02903030

COMPLETED

Helping Older Persons Emerge Stronger

NCT02863081

COMPLETED

Risk Factors for Post-Operative Respiratory Complications in Patients at Risk for OSA

NCT02729077

COMPLETED

Neurodevelopment in Infants With Complex Congenital Heart Defects

NCT03104751

COMPLETED NA

Impact of Glycine Therapy on Peri-implant Mucositis

NCT05810558

COMPLETED NA

Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat

NCT02482610

COMPLETED

Complement and Cardiovascular Risk in Adolescents

NCT02821104

TERMINATED NA

Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention

NCT02818283

COMPLETED Phase 4

Improving Beta Cell Function in Mexican American Women With Prediabetes

NCT02488057

COMPLETED NA

Therapist and Parent Delivered Reciprocal Imitation Training for Young Children With Autism Spectrum Disorder

NCT03020927

COMPLETED Phase 1

Natreon Healthy Skin Study - PrimaVie Supplement

NCT02762032

COMPLETED NA

Comparison of Local Only Anesthesia Versus Sedation in Patients Undergoing Bilateral Carpal Tunnel Release

NCT03495466

COMPLETED NA

Nudging for Behavior Change in School Cafeterias

NCT04156542

COMPLETED NA

The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting

NCT03034694

COMPLETED NA

Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting

NCT03036358

COMPLETED

Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty

NCT02989155

← Previous Page 8 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 35
Phase 2 25
Phase 3 5
Phase 4 34

What is open in the Ohio State University pipeline

117 recruiting of 552 indexed (21% open); 319 completed (58%).

Phase mix: 39 late (III/IV) vs 60 early (I/II) (early-phase heavy).

Top condition: Suicidal Ideation (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ohio State University: open-pipeline peers nationwide

Peers matched on 552 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Ohio State UniversityAmgenMerck Sharp & DohmeVirginia Commonwealth UniversityOregon Health and Science UniversityUniversity of LouisvilleMedical College of WisconsinNova Southeastern UniversityColorado State University
Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 552 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this Ohio State University page

552 registered trials is a research-attention snapshot, not an endorsement of Ohio State University or any single study.

  • 117 of Ohio State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Suicidal Ideation is the condition Ohio State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Suicidal Ideation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ohio State University pipeline card: 552 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.